Web Results



[edit]. Sanofi was founded in 1973 as subsidiary of Elf Aquitaine (a French oil company subsequently acquired by ...

Sanofi-Synthelabo lands Aventis for $64 billion - Apr. 26, 2004


Apr 26, 2004 ... NEW YORK (CNN/Money) - France's largest drugmaker Aventis will stay under French control after smaller rival Sanofi-Synthelabo raised its ...

Sanofi-Aventis merger completes - Outsourcing-Pharma


Aug 23, 2004 ... Sanofi-Synthelabo said earlier this month it would push for 100 per cent control of its former rival and newly-acquired subsidiary Aventis after ...

Sanofi-Synthelabo Inc.: Private Company Information - Businessweek


Sanofi-Synthelabo Inc. company research & investing information. Find executives and the latest company news.

Sanofi to Swallow Aventis in a Deal Set at $65 Billion - WSJ


Aventis agreed to be acquired by rival French drug maker Sanofi for about $65 ... Sunday agreed to be swallowed by its smaller rival, Sanofi-Synthelabo SA, ...

BioSpace - Sanofi-Synthelabo News, Search Jobs, Events


Aug 29, 2001 ... Sanofi-Synthelabo is a global healthcare company. With annual sales in excess of $5.5 billion and 30,000 employees in more than 100 ...

Contact us - Sanofi U.S.


For more specific requests, you can send a brief online form (noted by Image of Document Icon in the list below) to the appropriate Sanofi US contact or you can  ...

Sanofi-Synthelabo Inc - Bridgewater, NJ - HMO in Bridgewater, New ...


Get information, directions, products, services, phone numbers, and reviews on Sanofi-Synthelabo in Bridgewater, NJ. Discover more Offices and Clinics of ...

Sanofi in India - Sanofi-Synthelabo (India) Private Limited


Oct 1, 2015 ... Healthcare professionals seeking abbreviated prescribing information of the prescription product portfolio of Sanofi-Synthelabo (India) Private ...

Sanofi-Aventis | French company | Britannica.com


Dec 11, 2014 ... Sanofi-Aventis, French pharmaceutical company founded in 2004 through the merger of Sanofi-Synthélabo SA and a much larger French firm, ...

Popular Q&A
Q: What are solpadol (Sanofi-synthelabo) tablets used for
A: Solpadol caplets, capsules and effervescent tablets all contain two active ingredients, paracetamol and codeine phosphate. Used to treat severe pain. Read More »
Source: www.kgbanswers.co.uk
Q: What about xaliproden, the drug Sanofi-Synthelabo is testing and ...
A: It's said to be an oral neurotrophic factor enhancer. It's said to increase endogenous [inside the body] neurotrophic factors, particularly BDNF. The company di... Read More »
Source: www.als-mda.org
Helpful Resources

Sanofi U.S. - Sanofi US researches, develops and brings to market ...


Find Sanofi US corporate information, pharmaceutical products, news, career opportunities and health resources.

Sanofi - Our history


The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to ...

Sanofi - A global healthcare leader focused on patients' needs


Sanofi, a global healthcare leader focused on patients' needs, with diversified offering of medicines, consumer healthcare products, generics, animal health and ...